Food and Nutraceutical Applications of Chinese Herbal Products

  • Priya Kathirvel
  • Phillip Joy
  • Bohdan L. Luhovyy


Traditional Chinese medicine (TCM) is undergoing rapid growth and development in China and worldwide. Risks and benefits associated with Chinese herbal products, that are consumed as functional foods or nutraceuticals, requires further understanding before entering new markets including Canada.


Traditional Chinese Medicine Functional Food Herbal Remedy Chinese Herb Herbal Product 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Helmut Kaiser Consultancy (2013) Traditional Chinese Medicine (TCM) In China and Worldwide. Available at Accessed on 06 Aug 2013
  2. 2.
    Nutrition Business Journal (2008) Integrative medicine stakeholders organize to address healthcare crisis integrative medicine is on the rise in the United States. Nutr Bus J XII 11:1–13Google Scholar
  3. 3.
    Nutrition Business Journal (2012) 2012 Supplement Business Report. Executive summary available at Accessed on 08 Aug 2013
  4. 4.
    National Center for Complementary and Alternative Medicine (2009) Traditional chinese medicine: An introduction. Available at Accessed on 22 Sept 2013
  5. 5.
    Qian et al (2012) Effect of salvia miltiorrhiza hydrophilic extract on antioxidant enzymes in diabetic patients with chronic heart disease: a randomized controlled trial. Phytotherapy Res 26(1):60–66. doi: 10.1002/ptr.3513 CrossRefGoogle Scholar
  6. 6.
    Health Canada (2013) A new approach to natural health products. Available at: Accessed on 05 Aug 2013
  7. 7.
    Health Canada (2013) Harper Government Continues to Engage with Traditional Chinese Medicine Community in Canada. Available at: Accessed on 05 Aug 2013
  8. 8.
    Health Canada (2011) Natural Health Product Tracking Survey—2010 Final Report. Prepared by: Ipsos Reid. Available at Accessed on 21 Sept 2013
  9. 9.
    Government of Canada (2003) Natural Health Products Regulations (SOR/2003-196), Canada Gazette Part II, vol 137, no 13. Available at Accessed on 22 Sept 2013
  10. 10.
    Quan et al (2008) Complementary and alternative medicine use among Chinese and white Canadians. Can Fam Physician 54(11):1563–1569. doi: 10.54/11/1563 [pii]Google Scholar
  11. 11.
    Government of Canada (1985) Food and Drugs Act (R.S.C., 1985, c. F-27). Available at Accessed on 22 Sept 2013
  12. 12.
    Government of Canada (2007) Regulations Amending Schedule A to the Food and Drugs Act and the Medical Devices Regulations—Project 1539 (SOR/2007-288). Canada Gazette Part II, vol 141, no 26. Available at Accessed on 22 Sept 2013
  13. 13.
    U.S. Food and Drug Administration (2004) Botanical Drug Products. Guidance for Industry. Available at Accessed on 22 Sept 2013
  14. 14.
    The European Parliament and the Council of the European Union (2004) Directive 2004/24/EC of the European Parliament and of the Council of 31 March 2004 amending, as regards traditional herbal medicinal products. Official J Eur Union 47:85–90Google Scholar
  15. 15.
    European Medicines Agency (2013) The Committee on Herbal Medicinal Products Overview. Available at Accessed on 22 Sept 2013
  16. 16.
    European Food Safety Authority (2012) Compendium of botanicals reported to contain naturally occuring substances of possible concern for human health when used in food and food supplements. EFSA J 10(5):2663Google Scholar
  17. 17.
    Collins (2011) A ten-year audit of traditional Chinese medicine and other natural product research published in the Chinese Medical Journal (2000–2009). Chin Med J 124(9):1401–1408. doi: 10.3760/cma.j.issn.0366-6999.2011.09.023 Google Scholar
  18. 18.
    Boik (ed) (1995) Cancer and natural medicine: a textbook of basic science and clinical research. Oregon Medical Press, PrincetonGoogle Scholar
  19. 19.
    Wang et al (2006) Study on combination components and effectiveness of Chinese traditional herbal formulas. China J Chin Mat Med 31(1):5–9Google Scholar
  20. 20.
    Fong et al (2006) Evidence-based herbal medicine: challenges in efficacy and safety assessments. Curr Rev Chin Med 2:11–26. doi: 10.1142/9789812774019_0002 CrossRefGoogle Scholar
  21. 21.
    Zhu and Woerdenbag (1995) Traditional Chinese herbal medicine. Pharm World Sci 17(4):103–112. doi: 10.1007/bf01872386 CrossRefGoogle Scholar
  22. 22.
    Fong (2002) Integration of herbal medicine into modern medical practices: issues and prospects. Integr Cancer Ther 1(3):287–293CrossRefGoogle Scholar
  23. 23.
    Fitzloff et al (1998) Perspectives on the quality assurance of ginseng products in North America. In: Advances in Ginseng Research—Proceedings of the 7th International Symposium on Ginseng, Seoul, KoreaGoogle Scholar
  24. 24.
    Gilroy et al (2003) Echinacea and truth in Labeling. Arch Intern Med 163(6):699–704. doi: 10.1001/archinte.163.6.699 CrossRefGoogle Scholar
  25. 25.
    Liva (2009) Controlled testing: the cornerstone of all quality natural products. Integr Med 8(2):40–42Google Scholar
  26. 26.
    Tang et al (2009) Modern understanding for “eighteen incompatible medicaments” and “nineteen medicaments of mutual restraint” in TCM. Chin J Exp Trad Med Formulae 15(6):79–82Google Scholar
  27. 27.
    Ulbricht et al (2008) Clinical evidence of herb-drug interactions: a systematic review by the natural standard research collaboration. Curr Drug Metab 9(10):1063–1120CrossRefGoogle Scholar
  28. 28.
    Zhou et al (2007) Identification of drugs that interact with herbs in drug development. Drug Discovery Today 12(15–16):664–673. doi: 10.1016/j.drudis.2007.06.004 CrossRefGoogle Scholar
  29. 29.
    Gagnier et al (2006) Recommendations for reporting randomized controlled trials of herbal interventions: explanation and elaboration. J Clin Epidemiol 59(11):1134–1149. doi: 10.1016/j.jclinepi.2005.12.020 CrossRefGoogle Scholar
  30. 30.
    Gagnier et al (2006) Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med 144(5):364–367CrossRefGoogle Scholar
  31. 31.
    Liu et al (2013) Prospective registration, bias risk and outcome-reporting bias in randomised clinical trials of traditional Chinese medicine: an empirical methodological study. BMJ open 3(7):e002968. doi: 10.1136/bmjopen-2013-002968 CrossRefGoogle Scholar
  32. 32.
    Malla et al (2013) Assessing the functional foods and natural health products industry: a comparative overview and literature review. Canadian Agricultural Innovation and Regulation (CAIRN) Network. Available at Accessed on 30 Aug 2013
  33. 33.
    Kaur, Das (2011) Functional foods: an overview. Food Sci Biotechnol 20(4):861–875. doi: 10.1007/s10068-011-0121-7 CrossRefGoogle Scholar
  34. 34.
    Evani (2009) Tendances du marché américain en matière d’aliments, de boissons et d’ingrédients fonctionnels. Institute of Food Technologists. Available at Accessed on 26 July 2013
  35. 35.
    Cinnamon (2007) Results from the Functional Foods and Natural Health Products Survey -2007. Statistics Canada. Available at Accessed on 01 July 2013
  36. 36.
    Stein AJ, Rodriguez-Cerezo E (2008) Functional Food in the European Union, Institute for Prospective Technological Studies (IPTS), Technical report series EUR 23380 EN-2008. Available at Accessed on 30 Aug 2013
  37. 37.
    Trueman (2009) Functional foods. Patents and health claims, IP Strategist Publication, Nerac IncGoogle Scholar
  38. 38.
    Vuong (2004) Obtaining a quantity of ripen fruits of Momordica cochinchinensis plant (spinyl melon), collecting aril and seeds from the cavity of the fruit, separating aril from the seeds, drying wet aril, extracting oil from the aril. Patent Publication number US20040024275 A1, Publication date 5 Feb 2004Google Scholar
  39. 39.
    Green R, Owusu-Ansah YJ (1999) Natural heat stable flavorings for bakery applications. Patent Publication number US5902622 A, Publication date 11 May 1999Google Scholar
  40. 40.
    Mennett et al (2004) The use of labiatae herb preparations for foam enhancement of beverages. Patent Publication number CA2538766 A1, Publication date 31 March 2005Google Scholar
  41. 41.
    Morazzoni et al (2005) Use of ginkgo complexes for the enhancement of cognitive functions and the alleviation of mental fatigue. Patent Publication number CA2554760 A1, Publication date 18 Aug 2005Google Scholar
  42. 42.
    Nielsen SVS, Teisen-Simony C (2011) Appetite regulating dietary supplement. Patent Publication number CA2781740 A1, Publication date 3 June 2011Google Scholar
  43. 43.
    Kong (2002) Fermented herbal drink. Patent Publication number CA2325751 A1, Publication date 2 May 2002Google Scholar
  44. 44.
    Adachi et al (2011) Flavor deterioration inhibitor and inhibitor for the generation of citral deterioration smell. Patent Publication number CA2489390 C, Publication date 19 July 2011Google Scholar
  45. 45.
    Health Canada (2013) Licensed natural health products database. Available at]. Accessed on: 30 Aug 2013
  46. 46.
    Carroll et al (2011) Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prevent Res 4(3):354–364. doi: 10.1158/1940-6207.capr-10-0098 CrossRefGoogle Scholar
  47. 47.
    Chuengsamarn et al (2012) Curcumin extract for prevention of type 2 diabetes. Diabetes Care 35(11):2121–2127. doi: 10.2337/dc12-0116 CrossRefGoogle Scholar
  48. 48.
    Khajehdehi et al (2011) Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-beta and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study. Scand J Urol Nephrol 45(5):365–370. doi: 10.3109/00365599.2011.585622 CrossRefGoogle Scholar
  49. 49.
    Mohammadi et al (2013) Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. Phytotherapy Res 27(3):374–379. doi: 10.1002/ptr.4715 CrossRefGoogle Scholar
  50. 50.
    Rasyid, Lelo (1999) The effect of curcumin and placebo on human gall bladder function: an ultrasound study. Aliment Pharmacol Ther 13(2):245–249CrossRefGoogle Scholar
  51. 51.
    Satoskar et al (1986) Evaluation of antiinflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int J Clin Pharmacol Ther 24(12):651–654Google Scholar
  52. 52.
    Wongcharoen et al (2012) Effects of curcuminoids on frequency of acute myocardial infarction after coronary artery bypass grafting. Am J Cardiol 110(1):40–44. doi: 10.1016/j.amjcard.2012.02.043 CrossRefGoogle Scholar
  53. 53.
    Albrecht et al (2004) Efficacy and safety of the platelet-activating factor receptor antagonist BN 52021 (Ginkgolide B) in patients with severe sepsis—a randomised, double-blind, placebo-controlled, multicentre trial. Clin Drug Investig 24(3):137–147. doi: 10.2165/00044011-200424030-00002 CrossRefGoogle Scholar
  54. 54.
    Brinkley et al (2010) Effect of ginkgo biloba on blood pressure and incidence of hypertension in elderly men and women. Am J Hypertens 23(5):528–533. doi: 10.1038/ajh.2010.14 CrossRefGoogle Scholar
  55. 55.
    Brochet et al (1995) Double blind placebo controlled multicentre study of ginkgolide B in treatment of acute exacerbations of multiple sclerosis. The ginkgolide study group in multiple sclerosis. J Neurol Neurosurg Psychiatry 58(3):360–362CrossRefGoogle Scholar
  56. 56.
    Oskouei et al (2013) The effect of ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial. J Stroke Cerebrovas Dis 22(8):E557–E563. doi: 10.1016/j.jstrokecerebrovasdis.2013.06.010 CrossRefGoogle Scholar
  57. 57.
    Vellas et al (2012) Long-term use of standardised ginkgo biloba extract for the prevention of alzheimer’s disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol 11(10):851–859. doi: 10.1016/s1474-4422(12)70206-5 CrossRefGoogle Scholar
  58. 58.
    Zhang et al (2013) Ginkgo biloba extract for patients with early diabetic nephropathy: a systematic review. Evid Based Complement Altern Med eCAM 2013:689142–689142. doi: 10.1155/2013/689142 Google Scholar
  59. 59.
    Zhao et al (2012) Effects of ginkgo biloba extract in improving episodic memory of patients with mild cognitive impairment: a randomized controlled trial. J Chin Integr Med 10(6):628–634CrossRefGoogle Scholar
  60. 60.
    Khan et al (2003) Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 26(12):3215–3218. doi: 10.2337/diacare.26.12.3215 CrossRefGoogle Scholar
  61. 61.
    Leach MJ and Kumar S (2012) Cinnamon for diabetes mellitus. Cochrane Database Syst Rev 9. doi: 10.1002/14651858.CD007170.pub2
  62. 62.
    Mang et al (2006) Effects of a cinnamon extract on plasma glucose, HbA(1c), and serum lipids in diabetes mellitus type 2. Eur J Clin Invest 36(5):340–344. doi: 10.1111/j.1365-2362.2006.01629.x CrossRefGoogle Scholar
  63. 63.
    Vanschoonbeek et al (2006) Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients. J Nutr 136(4):977–980. doi: 10.136/4/977 [pii]Google Scholar
  64. 64.
    de Andrade et al (2007) Study of the efficacy of Korean red ginseng in the treatment of erectile dysfunction. Asian J Androl 9(2):241–244. doi: 10.1111/j.1745-7262.2007.00210.x CrossRefGoogle Scholar
  65. 65.
    Hong et al (2002) A double-blind crossover study evaluating the efficacy of Korean red ginseng in patients with erectile dysfunction: a preliminary report. J Urol 168(5):2070–2073. doi: 10.1097/01.ju.0000034387.21441.87 CrossRefGoogle Scholar
  66. 66.
    Liu et al (2012) Ginsenoside-Rd improves outcome of acute ischaemic stroke—a randomized, double-blind, placebo-controlled, multicenter trial. Eur J Neurol 19(6):855–863. doi: 10.1111/j.1468-1331.2011.03634.x CrossRefGoogle Scholar
  67. 67.
    Scholey et al (2010) Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study. Psychopharmacology 212(3):345–356. doi: 10.1007/s00213-010-1964-y CrossRefGoogle Scholar
  68. 68.
    Vuksan et al (2008) Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: Results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutr Metab Cardiovasc Dis 18(1):46–56. doi: 10.1016/j.numecd.2006.04.003 CrossRefGoogle Scholar
  69. 69.
    Ziemba et al (1999) Ginseng treatment improves psychomotor performance at rest and during graded exercise in young athletes. Int J Sport Nutr 9(4):371–377Google Scholar
  70. 70.
    Alizadeh-Navaei et al (2008) Investigation of the effect of ginger on the lipid levels a double blind controlled clinical trial. Saudi Med J 29(9):1280–1284Google Scholar
  71. 71.
    Zick et al (2009) Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting. Support Care Cancer 17(5):563–572. doi: 10.1007/s00520-008-0528-8 CrossRefGoogle Scholar
  72. 72.
    Yang et al (2012) A randomized, double-blind, placebo-controlled study to evaluate the efficacy and tolerability of Fufang Danshen (salvia miltiorrhiza) as add-on antihypertensive therapy in taiwanese patients with uncontrolled hypertension. Phytotherapy Res 26(2):291–298. doi: 10.1002/ptr.3548 CrossRefGoogle Scholar
  73. 73.
    Kimura et al (2007) Food-grade mulberry powder enriched with 1-deoxynojirimycin suppresses the elevation of postprandial blood glucose in humans. J Agric Food Chem 55(14):5869–5874. doi: 10.1021/jf062680g CrossRefGoogle Scholar
  74. 74.
    Alvin et al (2011) A comparative study of the safety and efficacy of 75 % mulberry (morus alba) extract oil versus placebo as a topical treatment for melasma: a randomized, single-blind, placebo-controlled trial. J Drugs Dermatol 10(9):1025–1031Google Scholar
  75. 75.
    Chen CC et al (2012) Chinese herb astragalus membranaceus enhances recovery of hemorrhagic stroke: double-blind, placebo-controlled, randomized study. Evidence-Based Complementary and Alternative Medicine. doi:  10.1155/2012/708452
  76. 76.
    Matkovic et al (2010) Efficacy and safety of astragalus membranaceus in the treatment of patients with seasonal allergic rhinitis. Phytotherapy Res 24(2):175–181. doi: 10.1002/ptr.2877 Google Scholar
  77. 77.
    Chen et al (2012) A novel infusible botanically-derived drug, PG2, for cancer-related fatigue: a phase II double-blind, randomized placebo-controlled study. Clin Invest Med 35(1):E1–E11Google Scholar
  78. 78.
    Al-Bareeq et al (2010) Dong Quai (Angelica sinensis) in the treatment of hot flashes for men on androgen deprivation therapy: results of a randomized double-blind placebo controlled trial. Cuaj-Can Urol Assoc J 4(1):49–53Google Scholar
  79. 79.
    Hirata et al (1997) Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil Steril 68(6):981–986CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2015

Authors and Affiliations

  • Priya Kathirvel
    • 1
  • Phillip Joy
    • 1
  • Bohdan L. Luhovyy
    • 1
  1. 1.Department of Applied Human NutritionMount Saint Vincent UniversityHalifaxCanada

Personalised recommendations